Thomas Moyer, Ph.D., from the Department of Laboratory Medicine and Pathology at Mayo Clinic, describes how hospitalization rates for heart patients taking warfarin, the worlds most-prescribed blood thinner, dropped by approximately 30 percent when genetic information was available to doctors when prescribing the drug.